EDGAR Filing Documents for 0001171843-15-001117

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:

SEC Accession No. 0001171843-15-001117

Filing Date

2015-02-27

Accepted

2015-02-26 21:44:56

Documents

Period of Report

2014-11-30

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 20-F	gff20f_022615.htm	20-F	1637219
2	EXHIBIT 4.65	exh_465.htm	EX-4.65	9151
3	EXHIBIT 4.66	exh_466.htm	EX-4.66	3413
4	EXHIBIT 8.1	exh_81.htm	EX-8.1	1345
5	EXHIBIT 12.1	exh_121.htm	EX-12.1	7650
6	EXHIBIT 12.2	exh_122.htm	EX-12.2	7676
7	EXHIBIT 13.1	exh_131.htm	EX-13.1	4473
8	EXHIBIT 13.2	exh_132.htm	EX-13.2	4210
9	EXHIBIT 15.1	exh_151.htm	EX-15.1	3959
16	GRAPHIC	image_002.gif	GRAPHIC	7084
17	GRAPHIC	exh81.jpg	GRAPHIC	93086
	Complete submission text file	0001171843-15-001117.txt		10189453

Data Files

Seq	Description	Document	Type	Size
10	XBRL INSTANCE FILE	ipci-20141130.xml	EX-101.INS	1345304
11	XBRL SCHEMA FILE	ipci-20141130.xsd	EX-101.SCH	91166
12	XBRL CALCULATION FILE	ipci-20141130_cal.xml	EX-101.CAL	44637
13	XBRL DEFINITION FILE	ipci-20141130_def.xml	EX-101.DEF	394729
14	XBRL LABEL FILE	ipci-20141130_lab.xml	EX-101.LAB	546572
15	XBRL PRESENTATION FILE	ipci-20141130_pre.xml	EX-101.PRE	400585

Mailing Address 30 WORCESTER ROAD TORONTO A6 M9W 5X2

Business Address 30 WORCESTER ROAD TORONTO A6 M9W 5X2 416-798-3001

Intellipharmaceutics International Inc. (Filer) CIK: 0001474835 (see all company filings)